Lebwohl, M. G., Sugarman, J. L., Gold, L. S., Lin, T., & Martin, G. (2019). Efficacy, Safety, and Tolerability of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination in the Treatment of Severe Plaque Psoriasis: Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials. SKIN The Journal of Cutaneous Medicine, 3, S29. https://doi.org/10.25251/skin.3.supp.29